标题
Antithrombotic therapy in diabetes: which, when, and for how long?
作者
关键词
-
出版物
EUROPEAN HEART JOURNAL
Volume -, Issue -, Pages -
出版商
Oxford University Press (OUP)
发表日期
2021-02-24
DOI
10.1093/eurheartj/ehab128
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Association of diabetes with outcomes in patients undergoing contemporary percutaneous coronary intervention: Pre-specified subgroup analysis from the randomized GLOBAL LEADERS study
- (2020) Ply Chichareon et al. ATHEROSCLEROSIS
- Effect of Dapagliflozin on Atrial Fibrillation in Patients with Type 2 Diabetes Mellitus: Insights from the DECLARE-TIMI 58 Trial
- (2020) Thomas A. Zelniker et al. CIRCULATION
- Meta-analysis of Dual Antiplatelet Therapy Versus Monotherapy With P2Y12 Inhibitors in Patients After Percutaneous Coronary Intervention
- (2020) Aaqib H. Malik et al. AMERICAN JOURNAL OF CARDIOLOGY
- Effectiveness, safety, and major adverse limb events in atrial fibrillation patients with concomitant diabetes mellitus treated with non-vitamin K antagonist oral anticoagulants
- (2020) Yi-Hsin Chan et al. Cardiovascular Diabetology
- The Role of Combination Antiplatelet and Anticoagulation Therapy in Diabetes and Cardiovascular Disease: Insights from the COMPASS Trial
- (2020) Deepak L. Bhatt et al. CIRCULATION
- Ticagrelor with or without Aspirin in High-Risk Patients with Diabetes Mellitus undergoing Percutaneous Coronary Intervention
- (2020) Dominick J. Angiolillo et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Rivaroxaban in Peripheral Artery Disease after Revascularization
- (2020) Marc P. Bonaca et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ticagrelor and Aspirin or Aspirin Alone in Acute Ischemic Stroke or TIA
- (2020) S. Claiborne Johnston et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ticagrelor monotherapy in patients with concomitant diabetes mellitus and chronic kidney disease: a post hoc analysis of the GLOBAL LEADERS trial
- (2020) Chao Gao et al. Cardiovascular Diabetology
- The long journey of individualizing antiplatelet therapy after acute coronary syndromes
- (2020) Robert F Storey EUROPEAN HEART JOURNAL
- Ticagrelor or Prasugrel in Patients With Acute Coronary Syndromes and Diabetes Mellitus
- (2020) Gjin Ndrepepa et al. JACC-Cardiovascular Interventions
- Trial Design Principles for Patients at High Bleeding Risk Undergoing PCI
- (2020) Davide Capodanno et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Anticoagulation in Patients with End-Stage Renal Disease and Atrial Fibrillation: Confusion, Concerns and Consequences
- (2020) Narender Goel et al. Journal of Stroke
- Impact of Diabetes Mellitus and Chronic Kidney Disease on Cardiovascular Outcomes and Platelet P2Y 12 Receptor Antagonist Effects in Patients With Acute Coronary Syndromes: Insights From the PLATO Trial
- (2019) Francesco Franchi et al. Journal of the American Heart Association
- Dual Antiplatelet or Dual Antithrombotic Therapy for Secondary Prevention in High-Risk Patients with Stable Coronary Artery Disease?
- (2019) Wael Sumaya et al. THROMBOSIS AND HAEMOSTASIS
- Antithrombotic Therapy for Stroke Prevention
- (2019) Graeme J. Hankey CIRCULATION
- 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
- (2019) Craig T. January et al. CIRCULATION
- Aspirin has potential benefits for primary prevention of cardiovascular outcomes in diabetes: updated literature-based and individual participant data meta-analyses of randomized controlled trials
- (2019) Samuel Seidu et al. Cardiovascular Diabetology
- Management of Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI
- (2019) Davide Capodanno et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Rivaroxaban Plus Aspirin Versus Aspirin in Relation to Vascular Risk in the COMPASS Trial
- (2019) Sonia S. Anand et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Antiplatelet Therapy After Noncardioembolic Stroke
- (2019) Jacoba P. Greving et al. STROKE
- Significance of circulating microRNAs in diabetes mellitus type 2 and platelet reactivity: bioinformatic analysis and review
- (2019) Justyna Pordzik et al. Cardiovascular Diabetology
- 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
- (2019) Francesco Cosentino et al. EUROPEAN HEART JOURNAL
- 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes
- (2019) Juhani Knuuti et al. EUROPEAN HEART JOURNAL
- Atrial Fibrillation and Diabetes Mellitus
- (2019) Allen Wang et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Pharmacokinetic/pharmacodynamic assessment of a novel, pharmaceutical lipid–aspirin complex: results of a randomized, crossover, bioequivalence study
- (2019) Dominick J. Angiolillo et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Ticagrelor with or without Aspirin in High-Risk Patients after PCI
- (2019) Roxana Mehran et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes
- (2019) Stefanie Schüpke et al. NEW ENGLAND JOURNAL OF MEDICINE
- Use of glycoprotein IIb/IIIa antagonists to prevent stent thrombosis in morphine-treated patients with ST-elevation myocardial infarction
- (2019) Bastiaan Zwart et al. PLATELETS
- Anticoagulation After Stroke in Patients With Atrial Fibrillation
- (2019) Riccardo Altavilla et al. STROKE
- Platelets as Potent Signaling Entities in Type 2 Diabetes Mellitus
- (2019) Etheresia Pretorius TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Ticagrelor in Patients with Stable Coronary Disease and Diabetes
- (2019) P. Gabriel Steg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Measurement of Thromboxane Biosynthesis in Health and Disease
- (2019) Carlo Patrono et al. Frontiers in Pharmacology
- Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
- (2019) William J. Powers et al. STROKE
- Effect of Liraglutide on Cardiovascular Events in Patients With Type 2 Diabetes Mellitus and Polyvascular Disease
- (2018) Subodh Verma et al. CIRCULATION
- European Heart Rhythm Association (EHRA) consensus document on management of arrhythmias and cardiac electronic devices in the critically ill and post-surgery patient, endorsed by Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Cardiac Arrhythmia Society of Southern Africa (CASSA), and Latin American Heart Rhythm Society (LAHRS)
- (2018) Giuseppe Boriani et al. EUROPACE
- Antithrombotic therapy and body mass: an expert position paper of the ESC Working Group on Thrombosis
- (2018) Bianca Rocca et al. EUROPEAN HEART JOURNAL
- The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
- (2018) Jan Steffel et al. EUROPEAN HEART JOURNAL
- Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial
- (2018) Sonia S Anand et al. LANCET
- Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA
- (2018) S. Claiborne Johnston et al. NEW ENGLAND JOURNAL OF MEDICINE
- Association of Diabetic Status and Glycemic Control With Ischemic and Bleeding Outcomes in Patients With Stable Coronary Artery Disease: The 5‐Year CORONOR Registry
- (2018) Gilles Lemesle et al. Journal of the American Heart Association
- Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention
- (2018) Dominick J. Angiolillo et al. CIRCULATION
- 2018 ESC/EACTS Guidelines on myocardial revascularization
- (2018) Franz-Josef Neumann et al. EUROPEAN HEART JOURNAL
- The Main Determinants of Diabetes Mellitus Vascular Complications: Endothelial Dysfunction and Platelet Hyperaggregation
- (2018) Albino Carrizzo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial
- (2018) Pascal Vranckx et al. LANCET
- Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus
- (2018) NEW ENGLAND JOURNAL OF MEDICINE
- 10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2019
- (2018) DIABETES CARE
- Addressing cardiovascular risk in type 2 diabetes mellitus: a report from the European Society of Cardiology Cardiovascular Roundtable
- (2018) Francesco Cosentino et al. EUROPEAN HEART JOURNAL
- 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
- (2017) Borja Ibanez et al. EUROPEAN HEART JOURNAL
- Enteric Coating and Aspirin Nonresponsiveness in Patients With Type 2 Diabetes Mellitus
- (2017) Deepak L. Bhatt et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- 5-Year Outcomes After Left Atrial Appendage Closure
- (2017) Vivek Y. Reddy et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease
- (2017) John W. Eikelboom et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease
- (2017) William R. Hiatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Consistent platelet inhibition with ticagrelor 60 mg twice-daily following myocardial infarction regardless of diabetes status
- (2017) Mark R. Thomas et al. THROMBOSIS AND HAEMOSTASIS
- Hyperglycaemia suppresses microRNA expression in platelets to increase P2RY12 and SELP levels in type 2 diabetes mellitus
- (2017) Zsolt Fejes et al. THROMBOSIS AND HAEMOSTASIS
- Risk of disseminated intravascular coagulation in patients with type 2 diabetes mellitus: retrospective cohort study
- (2017) Kenichiro Nogami et al. BMJ Open
- Early Recurrence and Major Bleeding in Patients With Acute Ischemic Stroke and Atrial Fibrillation Treated With Non–Vitamin‐K Oral Anticoagulants (RAF‐NOACs) Study
- (2017) Maurizio Paciaroni et al. Journal of the American Heart Association
- Atrial Fibrillation, Type 2 Diabetes, and Non–Vitamin K Antagonist Oral Anticoagulants
- (2017) Anna Plitt et al. JAMA Cardiology
- Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement
- (2016) Kirsten Bibbins-Domingo et al. ANNALS OF INTERNAL MEDICINE
- Flow cytometric analysis of platelets type 2 diabetes mellitus reveals ‘angry’ platelets
- (2016) Prashilla Soma et al. Cardiovascular Diabetology
- Diabetes Mellitus and Prevention of Late Myocardial Infarction After Coronary Stenting in the Randomized Dual Antiplatelet Therapy StudyCLINICAL PERSPECTIVE
- (2016) Ian T. Meredith et al. CIRCULATION
- Aspirin for Primary Cardiovascular Risk Prevention and Beyond in Diabetes Mellitus
- (2016) Davide Capodanno et al. CIRCULATION
- 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
- (2016) Paulus Kirchhof et al. EUROPEAN HEART JOURNAL
- Reduction in Ischemic Events With Ticagrelor in Diabetic Patients With Prior Myocardial Infarction in PEGASUS–TIMI 54
- (2016) Deepak L. Bhatt et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Validation of BARC Bleeding Criteria in Patients With Acute Coronary Syndromes
- (2016) Pascal Vranckx et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Platelet function monitoring to adjust antiplatelet therapy in elderly patients stented for an acute coronary syndrome (ANTARCTIC): an open-label, blinded-endpoint, randomised controlled superiority trial
- (2016) Guillaume Cayla et al. LANCET
- Effects of aspirin on risk and severity of early recurrent stroke after transient ischaemic attack and ischaemic stroke: time-course analysis of randomised trials
- (2016) Peter M Rothwell et al. LANCET
- Venous thromboembolism has the same risk factors as atherosclerosis
- (2016) Yuhong Mi et al. MEDICINE
- Antithrombotic therapy for secondary prevention of atherothrombotic events in cerebrovascular disease
- (2016) Davide Capodanno et al. Nature Reviews Cardiology
- Ticagrelor versus Aspirin in Acute Stroke or Transient Ischemic Attack
- (2016) S. Claiborne Johnston et al. NEW ENGLAND JOURNAL OF MEDICINE
- Short term versus long term dual antiplatelet therapy after implantation of drug eluting stent in patients with or without diabetes: systematic review and meta-analysis of individual participant data from randomised trials
- (2016) Giuseppe Gargiulo et al. BMJ-British Medical Journal
- Short term versus long term dual antiplatelet therapy after implantation of drug eluting stent in patients with or without diabetes: systematic review and meta-analysis of individual participant data from randomised trials
- (2016) Giuseppe Gargiulo et al. BMJ-British Medical Journal
- The ADAPTABLE Trial and Aspirin Dosing in Secondary Prevention for Patients with Coronary Artery Disease
- (2016) Abigail Johnston et al. Current Cardiology Reports
- Efficacy and safety of rivaroxaban in patients with diabetes and nonvalvular atrial fibrillation: The Rivaroxaban Once-daily, Oral, Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF Trial)
- (2015) Sameer Bansilal et al. AMERICAN HEART JOURNAL
- Diabetes mellitus and platelet reactivity in patients under prasugrel or ticagrelor treatment: an observational study
- (2015) Dimitrios Alexopoulos et al. Cardiovascular Diabetology
- Vorapaxar in Patients With Diabetes Mellitus and Previous Myocardial Infarction: Findings From the Thrombin Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events-TIMI 50 Trial
- (2015) M. A. Cavender et al. CIRCULATION
- Catheter ablation of atrial fibrillation in patients with diabetes mellitus: a systematic review and meta-analysis
- (2015) Matteo Anselmino et al. EUROPACE
- 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
- (2015) Marco Roffi et al. EUROPEAN HEART JOURNAL
- Comparison of dabigatran versus warfarin in diabetic patients with atrial fibrillation: Results from the RE-LY trial
- (2015) Michela Brambatti et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Association of Cardiometabolic Multimorbidity With Mortality
- (2015) Emanuele Di Angelantonio et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction
- (2015) Marc P. Bonaca et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comparative Efficacy and Safety of Different Antiplatelet Agents for Prevention of Major Cardiovascular Events and Leg Amputations in Patients with Peripheral Arterial Disease: A Systematic Review and Network Meta-Analysis
- (2015) Konstantinos Katsanos et al. PLoS One
- Platelets and diabetes mellitus
- (2015) Francesca Santilli et al. PROSTAGLANDINS & OTHER LIPID MEDIATORS
- Duration of Diabetes Mellitus and Risk of Thromboembolism and Bleeding in Atrial Fibrillation
- (2015) Thure Filskov Overvad et al. STROKE
- Early Recurrence and Cerebral Bleeding in Patients With Acute Ischemic Stroke and Atrial Fibrillation
- (2015) Maurizio Paciaroni et al. STROKE
- Risk of atrial fibrillation in diabetes mellitus: A nationwide cohort study
- (2015) Jannik L Pallisgaard et al. European Journal of Preventive Cardiology
- Impact of Intensive Glycemic Control on the Incidence of Atrial Fibrillation and Associated Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus (from the Action to Control Cardiovascular Risk in Diabetes Study)
- (2014) Omid Fatemi et al. AMERICAN JOURNAL OF CARDIOLOGY
- Association of metformin with lower atrial fibrillation risk among patients with type 2 diabetes mellitus: a population-based dynamic cohort and in vitro studies
- (2014) Shang-Hung Chang et al. Cardiovascular Diabetology
- Variations in Cause and Management of Atrial Fibrillation in a Prospective Registry of 15 400 Emergency Department Patients in 46 Countries
- (2014) Jonas Oldgren et al. CIRCULATION
- High coagulation factor levels and low protein C levels contribute to enhanced thrombin generation in patients with diabetes who do not have macrovascular complications
- (2014) Hyun Kyung Kim et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Impaired Responsiveness to the Platelet P2Y12 Receptor Antagonist Clopidogrel in Patients With Type 2 Diabetes and Coronary Artery Disease
- (2014) Dominick J. Angiolillo et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Novel antiplatelet agents in acute coronary syndrome
- (2014) Francesco Franchi et al. Nature Reviews Cardiology
- Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents
- (2014) Laura Mauri et al. NEW ENGLAND JOURNAL OF MEDICINE
- Overview of Platelet Physiology: Its Hemostatic and Nonhemostatic Role in Disease Pathogenesis
- (2014) Kakali Ghoshal et al. TheScientificWorldJOURNAL
- Antiplatelet and Anticoagulant Therapy for Atherothrombotic Disease: The Role of Current and Emerging Agents
- (2013) Dominick J. Angiolillo et al. American Journal of Cardiovascular Drugs
- Diabetes is associated with posttranslational modifications in plasminogen resulting in reduced plasmin generation and enzyme-specific activity
- (2013) R. A. Ajjan et al. BLOOD
- Vorapaxar in Patients With Peripheral Artery Disease
- (2013) Marc P. Bonaca et al. CIRCULATION
- Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis
- (2013) F Gerald R Fowkes et al. LANCET
- Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
- (2013) Christian T Ruff et al. LANCET
- Clopidogrel with Aspirin in Acute Minor Stroke or Transient Ischemic Attack
- (2013) Yongjun Wang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Edoxaban versus Warfarin in Patients with Atrial Fibrillation
- (2013) Robert P. Giugliano et al. NEW ENGLAND JOURNAL OF MEDICINE
- Platelets Derived From the Bone Marrow of Diabetic Animals Show Dysregulated Endoplasmic Reticulum Stress Proteins That Contribute to Increased Thrombosis
- (2012) Rodrigo Hernández Vera et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- The recovery of platelet cyclooxygenase activity explains interindividual variability in responsiveness to low-dose aspirin in patients with and without diabetes
- (2012) B. ROCCA et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Vorapaxar for secondary prevention of thrombotic events for patients with previous myocardial infarction: a prespecified subgroup analysis of the TRA 2°P-TIMI 50 trial
- (2012) Benjamin M Scirica et al. LANCET
- Effects of Clopidogrel Added to Aspirin in Patients with Recent Lacunar Stroke
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Vorapaxar in the Secondary Prevention of Atherothrombotic Events
- (2012) David A. Morrow et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Use of Antiplatelet Therapy in the Outpatient Setting: Canadian Cardiovascular Society Guidelines Executive Summary
- (2011) Alan D. Bell et al. CANADIAN JOURNAL OF CARDIOLOGY
- Standardized Bleeding Definitions for Cardiovascular Clinical Trials
- (2011) Roxana Mehran et al. CIRCULATION
- Pharmacodynamic Effects of Different Aspirin Dosing Regimens in Type 2 Diabetes Mellitus Patients With Coronary Artery Disease
- (2011) Davide Capodanno et al. Circulation-Cardiovascular Interventions
- Type 2 diabetes, glucose homeostasis and incident atrial fibrillation: the Atherosclerosis Risk in Communities study
- (2011) Rachel R Huxley et al. HEART
- Apixaban in Patients with Atrial Fibrillation
- (2011) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apixaban versus Warfarin in Patients with Atrial Fibrillation
- (2011) Christopher B. Granger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
- (2011) Manesh R. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban in Patients with a Recent Acute Coronary Syndrome
- (2011) Jessica L. Mega et al. NEW ENGLAND JOURNAL OF MEDICINE
- Twice daily dosing of aspirin improves platelet inhibition in whole blood in patients with type 2 diabetes mellitus and micro- or macrovascular complications
- (2011) Galia Spectre et al. THROMBOSIS AND HAEMOSTASIS
- Basic Principles of Platelet Biology and Clinical Implications
- (2010) Dominick J. Angiolillo et al. CIRCULATION JOURNAL
- Review article: Platelet abnormalities in diabetes mellitus
- (2010) José Luis Ferreiro et al. Diabetes & Vascular Disease Research
- Review article: Coagulation and fibrinolysis in diabetes
- (2010) SH Alzahrani et al. Diabetes & Vascular Disease Research
- Risk score to predict serious bleeding in stable outpatients with or at risk of atherothrombosis
- (2010) G. Ducrocq et al. EUROPEAN HEART JOURNAL
- Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the PLATelet inhibition and patient Outcomes (PLATO) trial
- (2010) Stefan James et al. EUROPEAN HEART JOURNAL
- Platelet membrane lipid fluidity and intraplatelet calcium mobilization in type 2 diabetes mellitus
- (2010) Cezary Watala et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Aspirin for Prevention of Cardiovascular Events in a General Population Screened for a Low Ankle Brachial IndexA Randomized Controlled Trial
- (2010) F. Gerald R. Fowkes JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Diabetes Mellitus, Glycemic Control, and Risk of Atrial Fibrillation
- (2010) Sascha Dublin et al. JOURNAL OF GENERAL INTERNAL MEDICINE
- Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial
- (2010) Jill J.F. Belch et al. JOURNAL OF VASCULAR SURGERY
- Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies
- (2010) The Emerging Risk Factors Collaboration LANCET
- Dose Comparisons of Clopidogrel and Aspirin in Acute Coronary Syndromes
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Patients with peripheral arterial disease in the CHARISMA trial
- (2009) P. P. Cacoub et al. EUROPEAN HEART JOURNAL
- Platelet thrombin receptor antagonism and atherothrombosis
- (2009) D. J. Angiolillo et al. EUROPEAN HEART JOURNAL
- Three-year follow-up and event rates in the international REduction of Atherothrombosis for Continued Health Registry
- (2009) M. J. Alberts et al. EUROPEAN HEART JOURNAL
- Insulin/IGF-1 hybrid receptor expression on human platelets: consequences for the effect of insulin on platelet function
- (2009) R.W. HUNTER et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation
- (2009) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
- (2009) Lars Wallentin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Greater Clinical Benefit of More Intensive Oral Antiplatelet Therapy With Prasugrel in Patients With Diabetes Mellitus in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel–Thrombolysis in Myocardial Infarction 38
- (2008) Stephen D. Wiviott et al. CIRCULATION
- Low-Dose Aspirin for Primary Prevention of Atherosclerotic Events in Patients With Type 2 DiabetesA Randomized Controlled Trial
- (2008) Hisao Ogawa JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Aspirin and Extended-Release Dipyridamole versus Clopidogrel for Recurrent Stroke
- (2008) Ralph L. Sacco et al. NEW ENGLAND JOURNAL OF MEDICINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started